Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)

SHA:603229 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,000	1,223	1,096	1,124	608.85	564.55
Trading Asset Securities	3.81	3.94	2.24	-	4.02	110
Cash & Short-Term Investments	1,004	1,227	1,099	1,124	612.87	674.55
Cash Growth	-12.81%	11.65%	-2.29%	83.44%	-9.14%	-8.73%
Accounts Receivable	359.5	146.41	196.58	132.75	134.81	66.24
Other Receivables	4.81	0.92	1.18	2.82	8.49	1.49
Receivables	364.32	147.34	197.76	135.57	143.3	67.73
Inventory	369.88	398.3	400.95	365.18	320.57	243.44
Other Current Assets	42.54	43.19	11.93	49.75	59.97	34.86
Total Current Assets	1,781	1,815	1,709	1,675	1,137	1,021
Property, Plant & Equipment	1,035	1,037	1,041	1,046	950.94	601.46
Long-Term Investments	101.06	72.56	72.56	67.37	50.14	32.64
Other Intangible Assets	149.54	151.56	155.39	150.37	161.98	164.2
Long-Term Deferred Tax Assets	7.72	3.82	0.46	-	6.87	4.47
Other Long-Term Assets	3.68	5.35	3.99	12.71	8.69	16.1
Total Assets	3,077	3,085	2,982	2,952	2,315	1,839

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	244.05	270.1	351.64	410.85	519.32	402.25
Accrued Expenses	20.3	49.38	46.87	40.11	42.91	31.63
Short-Term Debt	316.21	410.61	270.31	300.26	160.12	65.07
Current Portion of Long-Term Debt	1.07	0.51	-	-	9.16	-
Current Portion of Leases	-	1.28	1.04	0.87	-	-
Current Income Taxes Payable	15.87	-	2.53	10.21	-	5.81
Current Unearned Revenue	0.71	0.96	0.91	7.06	12.63	23.23
Other Current Liabilities	3.83	3.18	1.23	1.61	1.28	2.33
Total Current Liabilities	602.04	736.02	674.53	770.97	745.42	530.32
Long-Term Debt	44.25	44.25	-	-	72.74	44.86
Long-Term Leases	-	-	1.08	2.04	-	-
Long-Term Unearned Revenue	42.18	35.62	34.89	34.91	23.51	9.46
Long-Term Deferred Tax Liabilities	-	-	-	2.07	12.51	-
Total Liabilities	688.47	815.89	710.5	809.99	854.19	584.64

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	830.3	830.3	830.3	593.07	401.87	287.05
Additional Paid-In Capital	440.23	440.23	440.23	677.45	394.72	509.54
Retained Earnings	1,170	1,050	1,002	871.92	665.46	459.36
Treasury Stock	-50.01	-50.01	-	-	-	-
Comprehensive Income & Other	-1.36	-1.1	-0.83	-0.86	-0.91	-1.14
Shareholders' Equity	2,389	2,269	2,272	2,142	1,461	1,255
Total Liabilities & Equity	3,077	3,085	2,982	2,952	2,315	1,839

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	361.53	456.65	272.43	303.17	242.02	109.93
Net Cash (Debt)	642.34	769.86	826.1	821.06	370.85	564.62
Net Cash Growth	-21.65%	-6.81%	0.61%	121.40%	-34.32%	-19.12%
Net Cash Per Share	0.81	0.94	1.00	1.00	0.46	0.71
Filing Date Shares Outstanding	792.36	825.1	828.3	830.3	787.66	787.66
Total Common Shares Outstanding	792.36	825.1	830.3	830.3	787.66	787.66
Working Capital	1,179	1,079	1,035	903.76	391.28	490.26
Book Value Per Share	3.01	2.75	2.74	2.58	1.86	1.59
Tangible Book Value	2,239	2,118	2,116	1,991	1,299	1,091
Tangible Book Value Per Share	2.83	2.57	2.55	2.40	1.65	1.38
Buildings	-	314.84	261.11	224.84	168.11	150.71
Machinery	-	781.12	559.12	510.1	278.07	223.16
Construction In Progress	-	285.28	495.66	526.23	685.01	379.24

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 11, 2026

Data Sources Report a data error